Gastric dumping syndrome screening: Difference between revisions
No edit summary |
|||
| Line 20: | Line 20: | ||
*According to the [guideline name], screening for [disease name] is not recommended. | *According to the [guideline name], screening for [disease name] is not recommended. | ||
OR | OR | ||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with: | |||
*[Condition 1] | |||
*[Condition 2] | |||
*[Condition 3] | |||
* Intravenous fluid substitution is not effective in preventing early dumping symptoms.<ref name="pmid14452070">{{cite journal |vauthors=JOHNSON LP, SLOOP RD, JESSEPH JE |title=Etiologic significance of the early symptomatic phase in the dumping syndrome |journal=Ann. Surg. |volume=156 |issue= |pages=173–9 |year=1962 |pmid=14452070 |pmc=1466323 |doi= |url=}}</ref> | |||
The Sigstad score system is used to determine dumpers versus non-dumpers. | |||
{| class="wikitable" | |||
| colspan="2" |'''Sigstad score''' | |||
|- | |||
|Shock | |||
| +5 | |||
|- | |||
|Fainting, syncope, unconsciousness | |||
| +4 | |||
|- | |||
|Desire to lie or sit down | |||
| +4 | |||
|- | |||
|Breathlessness, dyspnoea | |||
| +3 | |||
|- | |||
|Weakness, exhaustion | |||
| +3 | |||
|- | |||
|Sleepiness, drowsiness, apathy, falling asleep | |||
| +3 | |||
|- | |||
|Palpitation | |||
| +3 | |||
|- | |||
|Restlessness | |||
| +2 | |||
|- | |||
|Dizziness | |||
| +2 | |||
|- | |||
|Headaches | |||
| +1 | |||
|- | |||
|Feeling of warmth, sweating, pallor, clammy skin | |||
| +1 | |||
|- | |||
|Nausea | |||
| +1 | |||
|- | |||
|Abdominal fullness, meteorism | |||
| +1 | |||
|- | |||
|Borborygmus | |||
| +1 | |||
|- | |||
|Eructation | |||
|−1 | |||
|- | |||
|Vomiting | |||
|} | |||
Revision as of 14:47, 12 December 2017
|
Gastric dumping syndrome Microchapters |
|
Differentiating Gastric dumping syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Gastric dumping syndrome screening On the Web |
|
American Roentgen Ray Society Images of Gastric dumping syndrome screening |
|
Risk calculators and risk factors for Gastric dumping syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
- There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
- According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]
- Intravenous fluid substitution is not effective in preventing early dumping symptoms.[1]
The Sigstad score system is used to determine dumpers versus non-dumpers.
| Sigstad score | |
| Shock | +5 |
| Fainting, syncope, unconsciousness | +4 |
| Desire to lie or sit down | +4 |
| Breathlessness, dyspnoea | +3 |
| Weakness, exhaustion | +3 |
| Sleepiness, drowsiness, apathy, falling asleep | +3 |
| Palpitation | +3 |
| Restlessness | +2 |
| Dizziness | +2 |
| Headaches | +1 |
| Feeling of warmth, sweating, pallor, clammy skin | +1 |
| Nausea | +1 |
| Abdominal fullness, meteorism | +1 |
| Borborygmus | +1 |
| Eructation | −1 |
| Vomiting | |